|
|
Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.
Company's pharmaceutical business is organized into domestic and international operations. Alkem Labs has a portfolio of over 736 brands in India. Company's most significant therapeutic areas in domestic market are anti-infectives, gastro-intestinal, pain and analgesics, and vitamins, minerals and nutrients.
Alkem Labs have a total of 16 manufacturing facilities: 14 manufacturing facilities at five locations in India and two in the United States. Company have four research and development facilities, two in India and two in the United States. As of June 30, 2015, company employed 483 scientists in research and development functions.
Highlights:
1. Alkem Labs is 5th largest pharmaceutical company in India in terms of domestic sales.
2. Alkem Labs products are also sold in 56 countries. In the United States, company has filed 66 abbreviated new drug applications.
3. Company sells a range of high-quality, cost effective generic drugs to major drug chains, pharmaceutical retailers, wholesalers, food and grocery stores, distributors and managed care companies in the United States.
Alkem Labs has 23 Promoters who jointly hold 64,302,440 Equity Shares of the Company which, in aggregate, constitutes 53.8% of the issued and paid-up Equity Share capital of our Company.
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Mar 15 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 33,595.20 | 28,395.80 | 24,690.10 | 20,640.10 |
| Profit After Tax (PAT) | 4,370.90 | 4,402.00 | 4,667.80 | 4,318.10 |
The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of 12,853,442 Equity Shares by the Selling Shareholders.
| IPO Opening Date | Dec 8, 2015 |
| IPO Closing Date | Dec 10, 2015 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹2 per equity share |
| IPO Price | ₹1020 to ₹1050 per equity share |
| Market Lot | 14 Shares |
| Min Order Quantity | 14 Shares |
| Listing At | BSE, NSE |
| Issue Size | 12,853,442 Eq Shares of ₹2 (aggregating up to ₹1,349.61 Cr) |
The Alkem Laboratories IPO market lot size is 14 shares. A retail-individual investor can apply for up to 13 lots (182 shares or ₹191,100).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 14 | ₹14,700 |
| Maximum | 13 | 182 | ₹191,100 |
The Alkem Laboratories IPO is subscribed 44.29x times on Dec 10, 2015 23:15. The public issue subscribed 3.17x in the retail category, 57.19x in the QIB category, and 129.96x in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | IPO Subscription |
|---|---|
| QIB | 57.19x |
| NII | 129.96x |
| RII | 3.17x |
| Employee | 0.67x |
| Total | 44.29x |
| Listing Date | Wednesday, December 23, 2015 |
| BSE Script Code | 539523 |
| NSE Symbol | ALKEM |
| Listing In | B Group of Securities |
| ISIN | INE540L01014 |
| IPO Price | ₹1050 per equity share |
| Face Value | ₹2 per equity share |
|
|
|
Alkem Laboratories Limited
Alkem House,
Senapati Bapat Marg,
Lower Parel, Mumbai 400 013
Phone: +91 22 3982 9999
Email: investors@alkem.com
Website: http://www.alkemlabs.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: all.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Alkem Laboratories IPO is a main-board IPO of 12,853,442 equity shares of the face value of ₹2 aggregating up to ₹1,349.61 Crores. The issue is priced at ₹1020 to ₹1050 per equity share. The minimum order quantity is 14 Shares.
The IPO opens on Dec 8, 2015, and closes on Dec 10, 2015.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Alkem Laboratories IPO opens on Dec 8, 2015 and closes on Dec 10, 2015.
Alkem Laboratories IPO lot size is 14 Shares and the minimum order quantity is 14 Shares.
You can apply in Alkem Laboratories IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Alkem Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Alkem Laboratories IPO allotment status.
Useful Articles
Rs 0 Eq Delivery Brokerage
Flat ₹10 Per Trade in F&O
Rs 0 Demat AMC
IPO Guru (4000+ Posts, 4600+ Likes)
